SPONSOR
Qilu Hospital of Shandong University
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 4
Conditions studied: HER2-positive Gastric CancerMetastatic Gastric CancerUnresectable Gastric CarcinomaUterine Cervical NeoplasmsAcute Coronary SyndromeHelicobacter Pylori InfectionStrokeArthritis, RheumatoidGastroesophageal Reflux DiseaseCoronary Microvascular Disease
Qilu Hospital of Shandong University is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma, Uterine Cervical Neoplasms.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qilu Hospital of Shandong University
How many clinical trials has Qilu Hospital of Shandong University sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Qilu Hospital of Shandong University, of which 11 are actively recruiting participants. These trials cover conditions including HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Hospital of Shandong University research focus on?
Qilu Hospital of Shandong University clinical trials span HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma, Uterine Cervical Neoplasms, Acute Coronary Syndrome, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Hospital of Shandong University clinical trial?
To participate in a Qilu Hospital of Shandong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Hospital of Shandong University trials with current recruitment status updated daily.
Clinical Trials by Qilu Hospital of Shandong University
NCT06730373 Phase 2
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
HER2-positive Gastric Cancer
NCT06558682
Recruiting
Neoadjuvant Therapy in Cervical Cancer
Uterine Cervical Neoplasms
NCT04728516 Phase 4
Recruiting
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Acute Coronary Syndrome
NCT07184892
Recruiting
Effects of Different Modes of Action Observation Therapy on Swallowing Function After Stroke: a Study Based on fNIRS
Stroke
NCT05626348 Phase 4
Recruiting
The Clinical Efficacy of Immunomodulators in RA Patients
Arthritis, Rheumatoid
NCT06348420
Recruiting
Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment
Gastroesophageal Reflux Disease
NCT06699420 Phase 4
Recruiting
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Coronary Microvascular Disease
NCT07809542
Recruiting
Brain Network Characteristics of Pain Patients Based on Magnetoencephalography
Muscle Pain
NCT06704074
Recruiting
Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
Stroke
NCT07275554
Recruiting
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
HBV Related Acute-on-chronic Liver Failure
NCT06711016
Recruiting
Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR
Cardiac Arrest
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology